Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
出版年份 2017 全文链接
标题
Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
作者
关键词
-
出版物
eLife
Volume 6, Issue -, Pages -
出版商
eLife Sciences Organisation, Ltd.
发表日期
2017-01-17
DOI
10.7554/elife.18173
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors
- (2016) Geoffrey Wayne Krampitz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adapting Cancer Immunotherapy Models for the Real World
- (2016) Lauryn E. Klevorn et al. TRENDS IN IMMUNOLOGY
- Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell function
- (2016) Andre Kleensang et al. Scientific Reports
- Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo
- (2016) Michael Zhang et al. PLoS One
- Estimating Tumor Growth Rates In Vivo
- (2015) Anne Talkington et al. BULLETIN OF MATHEMATICAL BIOLOGY
- Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
- (2015) M. Cioffi et al. CLINICAL CANCER RESEARCH
- CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models
- (2015) Ji-Feng Xu et al. Oncotarget
- Registered report: The CD47-signal regulated protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2015) Denise Chroscinski et al. eLife
- CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer
- (2015) Kazumichi Yoshida et al. Cancer Medicine
- Conducting Meta-Analyses inRwith themetaforPackage
- (2015) Wolfgang Viechtbauer Journal of Statistical Software
- Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
- (2015) Jie Liu et al. PLoS One
- Three major uncertainties in the antibody therapy of cancer
- (2014) G. T. Stevenson HAEMATOLOGICA
- What have we learned from cancer immunotherapy in the last 3 years?
- (2014) Paolo A Ascierto et al. Journal of Translational Medicine
- Standardised animal models of host microbial mutualism
- (2014) A J Macpherson et al. Mucosal Immunology
- Policy: NIH to balance sex in cell and animal studies
- (2014) Janine A. Clayton et al. NATURE
- An open investigation of the reproducibility of cancer biology research
- (2014) Timothy M Errington et al. eLife
- Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature
- (2013) K. M. Kokolus et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vivo mathematical modeling of tumor growth from imaging data: Soon to come in the future?
- (2013) F. Cornelis et al. Diagnostic and Interventional Imaging
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel Immunocompetent Murine Tumor Model for Evaluation of Conditionally Replication-Competent (Oncolytic) Murine Adenoviral Vectors
- (2009) M. Robinson et al. JOURNAL OF VIROLOGY
- Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic Cells
- (2008) G-One Ahn et al. CANCER CELL
- Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper
- (2008) Mette Munk Jensen et al. BMC MEDICAL IMAGING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started